Back
Raffles Medical Group Vs. ASLAN Pharmaceuticals Industry Stock Comparison
Sell
30
RAFLF
Raffles Medical Group
Last Price:
0.74
Seasonality Move:
2.11%
Sell
37
ASLN
ASLAN Pharmaceuticals
Last Price:
0.44
Seasonality Move:
6.49%
Sell
30
Raffles Medical Group (RAFLF)
is a Sell
Is Raffles Medical Group a Buy, Sell or Hold?
- The current Raffles Medical Group [RAFLF] share price is $0.74. The Score for RAFLF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RAFLF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
ASLAN Pharmaceuticals (ASLN)
is a Sell
Is ASLAN Pharmaceuticals a Buy, Sell or Hold?
- The current ASLAN Pharmaceuticals [ASLN] share price is $0.44. The Score for ASLN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ASLN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RAFLF Stock Price Chart
What is Raffles Medical Group's stock price today?
-
The Raffles Medical Group share price today is $0.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RAFLF is experiencing slight buying pressure.
ASLN Stock Price Chart
What is ASLAN Pharmaceuticals's stock price today?
-
The ASLAN Pharmaceuticals share price today is $0.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASLN is experiencing slight buying pressure.
RAFLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 17.39 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.74 - 0.74) | Sell |
| Bollinger Bands (100): | (0.72 - 0.76) | Sell |
ASLN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.85 | Sell |
| Chaikin Money Flow: | 38621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.41 - 0.49) | Sell |
| Bollinger Bands (100): | (0.42 - 0.72) | Sell |
RAFLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.74 | Sell |
| 20-day SMA: | 0.74 | Sell |
| 50-day SMA: | 0.74 | Sell |
| 200-day SMA: | 0.85 | Sell |
| 8-day EMA: | 0.74 | Sell |
| 20-day EMA: | 0.74 | Sell |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 0.82 | Sell |
ASLN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Buy |
| 20-day SMA: | 0.44 | Buy |
| 50-day SMA: | 0.56 | Sell |
| 200-day SMA: | 1 | Sell |
| 8-day EMA: | 0.42 | Buy |
| 20-day EMA: | 0.45 | Sell |
| 50-day EMA: | 0.51 | Sell |
| 200-day EMA: | 1.11 | Sell |
Raffles Medical Group Earnings Growth & RAFLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ASLAN Pharmaceuticals Earnings Growth & ASLN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.73 per share, and an increase next year of $0.99 per share.
Raffles Medical Group Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ASLAN Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||